A common gut bacterium rewires brain GABA receptors and reduces anxiety in mice

The idea that swallowing a bacterium could change how your brain handles stress sounds improbable, but a 2011 study published in PNAS by Javier Bravo, John Cryan, John Bienenstock, and colleagues at University College Cork made exactly that case. Mice fed a daily dose of Lactobacillus rhamnosus JB-1 for 28 days showed measurable changes in GABA receptor gene expression across multiple brain regions and behaved significantly less like anxious or depressed animals. The kicker: when the researchers cut the vagus nerve before starting the probiotic regimen, every neurochemical and behavioral effect vanished.

Lactobacillus rhamnosus JB-1 reshapes GABA receptor expression across brain regions

GABA (gamma-aminobutyric acid) is the central nervous system's primary braking signal. Receptors that respond to it come in several subtypes, and their distribution across brain regions governs everything from baseline anxiety to the physiological stress response. Alterations in GABA receptor subunit expression are directly linked to anxiety disorders and depression, which is why drugs like benzodiazepines target this system.

After 28 days of oral L. rhamnosus JB-1, the Cork team found that GABAB1b messenger RNA levels rose in the cingulate and prelimbic cortical regions while falling in the hippocampus, amygdala, and locus coeruleus. Simultaneously, GABAAα2 subunit mRNA decreased in the prefrontal cortex and amygdala but increased in the hippocampus. These are not random fluctuations: the prefrontal cortex and amygdala are central to fear processing, while the hippocampus regulates context and memory tied to stress. The region-specific pattern suggests the bacterium did not simply flood the brain with a uniform signal but produced a nuanced recalibration of inhibitory tone in precisely the circuits most relevant to emotional regulation.

Corticosterone levels, the rodent equivalent of cortisol, were also lower in treated animals after acute stress, adding a hormonal dimension to the picture.

Anxiety and depression-related behaviors fell measurably in treated mice

Neurochemistry alone does not make the case; behavior does. The researchers ran three standard tests. In the elevated plus maze, a cross-shaped platform with two open arms and two enclosed arms, mice that dislike open spaces spend most of their time in the enclosed sections. Mice given L. rhamnosus JB-1 spent significantly more time in the open arms, a reliable index of reduced anxiety. In the forced swim test, a measure of behavioral despair, treated animals spent less time floating immobile and more time actively swimming, a pattern associated with antidepressant-like effects.

The third test, stress-induced hyperthermia, measures the rise in body temperature triggered by handling stress. Here, no significant difference appeared between the probiotic and control groups. That null result matters: it suggests the bacterium did not produce a blanket blunting of all stress physiology but acted more selectively on anxiety- and mood-related circuits.

The vagotomy experiment identified the vagus nerve as the gut-brain conduit

The most decisive part of the study was methodological. To determine whether the effects truly depended on gut-to-brain signaling rather than some systemic route (circulating metabolites, immune mediators, or absorbed bacterial components), the team performed vagotomies on a separate cohort of mice before starting the probiotic protocol. The vagus nerve is the primary bidirectional highway between the enteric nervous system in the gut and the brain; cutting it severs that highway without removing the gut or disrupting the immune system.

Vagotomized mice that received L. rhamnosus JB-1 showed none of the GABA receptor changes seen in intact animals. Their behavior in the elevated plus maze and forced swim test was indistinguishable from controls. The corticosterone differences disappeared as well. In experimental design terms, vagotomy was an elegant intervention: it isolated the neural route without confounding the gut environment itself. The result pointed to the vagus nerve as the critical conduit through which L. rhamnosus JB-1 communicates with the brain.

Open questions: mouse-to-human translation and mechanisms beyond GABA

The study's authors were working in mice, and mouse-to-human extrapolation in behavioral neuroscience is notoriously unreliable. The elevated plus maze and forced swim test are validated proxies for anxiety and despair-like states in rodents, but they do not map cleanly onto diagnosed anxiety disorder or major depression in people. Human vagus nerve anatomy also differs from that of mice, and the microbiome compositions of the two species diverge substantially.

Within the mouse model itself, the study documented changes in GABA receptor mRNA but did not fully trace the upstream mechanism by which a gut bacterium triggers those transcriptional shifts. Whether L. rhamnosus JB-1 acts through vagal afferent neurons directly, through enteroendocrine cells that release gut peptides onto vagal terminals, or through some combination of routes remained an open question. The scope was also limited to two GABA receptor subunits; other neurotransmitter systems almost certainly participate in whatever the full gut-brain signal looks like.

Probiotic-based approaches to stress disorders: a research direction the study opened

The 2011 PNAS paper arrived when the microbiome field was still largely focused on metabolic and immune outcomes. By demonstrating that a single bacterial strain could produce region-specific changes in a major neurotransmitter receptor system, Bravo, Cryan, Bienenstock, and colleagues gave the gut-brain axis field a concrete, mechanistically tractable hypothesis to pursue: that some probiotics may function as psychobiotics, bacteria with measurable effects on brain chemistry and behavior.

The vagotomy finding also gave researchers a specific pathway to interrogate. Subsequent work in the field has explored which vagal afferent populations carry gut bacterial signals, how enteroendocrine cells sense luminal bacteria, and whether similar GABA modulation occurs in germ-free animals recolonized with defined bacterial strains. None of those follow-up questions would have been as sharply framed without the clean causal logic this study established.

For stress-related disorders, where current pharmacological options carry significant side-effect burdens, the prospect of leveraging gut bacteria to modulate central inhibitory tone remains a long-horizon but scientifically grounded research target. The distance from a mouse given L. rhamnosus JB-1 in 2011 to a validated human therapeutic is large, but the mechanistic specificity of this study, a named strain, a named nerve, named receptor subunits in named brain regions, made it a more durable foundation than most early microbiome-brain claims.